Breast Implant-Associated Anaplastic Large Cell Lymphoma Diagnosis

Diagnostic Limitations

Ultrasound has 84% sensitivity for detecting effusions, but can miss early disease when fluid collections are minimal or when malignant cells are present without significant fluid accumulation 1
MRI demonstrates 82% sensitivity for effusion detection and only 50% sensitivity for mass detection, with specificity of just 33% for effusions 1, 2
Both modalities can fail to detect disease when BIA-ALCL presents with microscopic involvement of the capsule without gross fluid or mass 3, 4

Late-onset seroma (>1 year post-implantation) is the hallmark presentation, occurring at a median of 8-10 years after implant placement 3, 4, 5, 6, 7
Clinical symptoms include breast swelling, asymmetry, fullness, or pain - these symptoms mandate investigation regardless of imaging findings 3, 4, 5
A small incidental volume of periprosthetic fluid may be normal, but any symptomatic presentation warrants aspiration 3, 4, 5
CD30 positivity is required by definition for BIA-ALCL diagnosis 3, 4, 5
Mammography has only 73% sensitivity and 50% specificity for detecting abnormalities and should not be relied upon 1, 2

If a patient with breast implants presents with new symptoms (swelling, asymmetry, sensation of fullness, pain) occurring >1 year after implantation, perform ultrasound examination first to assess for effusion or mass 3, 4, 5
If ultrasound shows ANY fluid collection (even if minimal), proceed immediately to ultrasound-guided aspiration for cytology, regardless of the volume 3, 4, 5, 8
If ultrasound is negative but clinical suspicion remains high, consider MRI as a second-line test 1, 2

If clinical suspicion remains high despite negative imaging and negative or non-diagnostic aspiration, consider proceeding to capsulectomy with complete pathologic examination of the capsule, as microscopic disease may be present without detectable fluid or mass 8
This is particularly important if the patient has textured implants, which carry higher BIA-ALCL risk 3, 4, 5, 9